Nosocomial Influenza Surveillance 2018 - 2022

NCT03413228 | Unknown

• 1 other identifier: 69HCL17_0868
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients notably elderly patients. Furthermore, it is also associated with a large economic impact for the hospitals. The transmission of influenza has been mostly reported in pediatric and long-stay units. The chains of transmission of influenza in acute-stay units have to be describe in order to prevent and control potential outbreaks. Furthermore, to know clinical symptoms seems to be important in order to identify potential sources of virus as soon as possible and to set up appropriate hygiene prevention measures. Moreover, the definition of the hospital-acquired influenza has to be harmonized for all over the studies, especially concerning the delay between the admission in the hospital and the symptoms onset. The aim of this study is to describe the hospital-acquired influenza in a french university hospital of around 800 beds

Conditions

Hospital-Acquired Infection; Influenza

Outcome Measures

Primary Outcomes (1)

• Proportion of patients and health-care workers who present an influenza illness.

  An interview to collect some informations will be done to evaluate if participants present symptoms of an inflenza illness (fever \> 37,8°C or/and cough or sore throat). Then, a nasal swab will be performed in order to identified the influenza virus.

  5 days maximum

Study Arms (1)

Influenza-like illness group

Other: Questionnaire

Interventions

Questionnaire OTHER

An interview to collect some informations will be done: demographic informations, medical history, vaccination against influenza status, symptoms and virological informations. Then, a nasal swab was performed in order to identified the influenza virus.

Influenza-like illness group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Each patient or health-care worker who present ILI (influenza-like illness) at admission or during hospitalization. ILI is defined by fever \> 37,8°C or/and cough or sore throat.

You may qualify if:

• Adult patients and health-care workers in a participating unit in the study,
• more than 18 years old,
• volunteers,
• who present an influenza-like illness defined by fever \> 37,8°C or/and cough or sore throat.

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Infection Control unit. Edouard Herriot hospital Lyon - France

Lyon, 69003, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

nasal swab

MeSH Terms

Conditions

Cross Infection; Influenza, Human

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Infections; Iatrogenic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Respiratory Tract Infections; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Central Study Contacts

Philippe VANHEMS, MD PhD

CONTACT

0472110719; philippe.vanhems@chu-lyon.fr

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 22, 2018
• First Posted: January 29, 2018
• Study Start: February 1, 2018
• Primary Completion: June 1, 2018
• Study Completion: June 1, 2022
• Last Updated: January 30, 2018

Record last verified: 2018-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)